Implantation of Long Acting Formulation of 5 alpha reducatase inhibitor to prevent prostate cancer, prostate hypertrophy, hirsutism, male and female pattern hair loss (androgenetic alopecia)

Details for Australian Patent Application No. 2009100505 (hide)

International Classifications

Event Publications

11 June 2009 Innovation Patent Application Filed

2 July 2009 Innovation Patent Open to Public Inspection

Published as AU-A-2009100505

2 July 2009 Innovation Patent Sealed

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143A(d), or Expired. Examination has not been requested on this patent. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.